Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-065193
Filing Date
2006-03-28
Accepted
2006-03-28 16:27:27
Documents
5
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 692510
2 CONSENT OF SWENSON ADVISORS, LLP dex231.htm EX-23.1 1724
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - SECTION 302 dex311.htm EX-31.1 10372
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER - SECTION 302 dex312.htm EX-31.2 10503
5 CERTIFICATION OF CEO AND CFO - SECTION 906 dex321.htm EX-32.1 4875
  Complete submission text file 0001193125-06-065193.txt   721514
Mailing Address 888 PROSPECT STREET SUITE 320 LA JOLLA CA 92037
Business Address 888 PROSPECT STREET SUITE 320 LA JOLLA CA 92037 8586460789
AKESIS PHARMACEUTICALS, INC. (Filer) CIK: 0001042420 (see all company filings)

EIN.: 841409219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27409 | Film No.: 06715365
SIC: 7389 Services-Business Services, NEC